Biotech Values

[drbio45]

it is funny that a zn would go up because of a bullish report by an analyst because of cerovive

if he thought the drug works he should be bullish on renovis

then he puts a peak sales number of 132 million to be conservative .

IF the drug works it is a billion to 2 billion dollar drug, if it doesn't works the sales are zero. there is no in between


stroke drug failures are littered with neuroprotectants, which are supposed to protect the brain from damage done during lack of oxygen getting to the brain caused by ischemic strokes. The best stroke drug will one that busts the clot earlier so the brain gets oxygen. when that drug is found a neuroprotectant may work

it is funny that azn would go up on that report and rnvs would go down